Advertisement
Screener

Beyond Air, Inc. (XAIR) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

Beyond Air, Inc. Research and Development Expense

Beyond Air, Inc. (XAIR) reported Research and Development Expense of $1.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13

  • Beyond Air, Inc. research and development expense for the quarter ending 2026-06-30 was $1.96M, a 36.52% decline year-over-year.
  • Beyond Air, Inc. research and development expense for the quarter ending 2026-03-31 was $2.28M, a 30.14% decline year-over-year.
  • Beyond Air, Inc. research and development expense for the quarter ending 2025-12-31 was $2.43M, a 19.17% decline year-over-year.
  • Beyond Air, Inc. research and development expense for the quarter ending 2025-09-30 was $2.45M, a 46.56% decline year-over-year.
  • Beyond Air, Inc. research and development expense for fiscal 2026 was $10.24M, a 39.25% decline from fiscal 2025.
  • Beyond Air, Inc. research and development expense for fiscal 2025 was $16.86M, a 30.81% decline from fiscal 2024.
  • Beyond Air, Inc. research and development expense for fiscal 2024 was $24.36M, a 44.93% increase from fiscal 2023.
  • Beyond Air, Inc. research and development expense for fiscal 2023 was $16.81M, a 42.43% increase from fiscal 2022.
Period endResearch and Development Expense 0 monthResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-06-30$1.96M
10-Q · filed 2026-08-13
$4.24M
derived: sum of 2 quarters · filed 2026-08-13
$6.66M
derived: sum of 3 quarters · filed 2026-08-13
$9.11M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$2.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26
$4.71M
derived: sum of 2 quarters · filed 2026-06-26
$7.16M
derived: sum of 3 quarters · filed 2026-06-26
$10.24M
10-K · filed 2026-06-26
2025-12-31$2.43M
10-Q · filed 2026-02-13
$4.88M
derived: sum of 2 quarters · filed 2026-02-13
$7.96M
10-Q · filed 2026-02-13
$11.22M
derived: sum of 4 quarters · filed 2026-08-13
2025-09-30$2.45M
10-Q · filed 2025-11-10
$5.54M
10-Q · filed 2025-11-10
$8.79M
derived: sum of 3 quarters · filed 2026-08-13
$11.80M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$3.09M
10-Q · filed 2026-08-13
$6.34M
derived: sum of 2 quarters · filed 2026-08-13
$9.35M
derived: sum of 3 quarters · filed 2026-08-13
$13.93M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$3.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26
$6.26M
derived: sum of 2 quarters · filed 2026-06-26
$10.85M
derived: sum of 3 quarters · filed 2026-06-26
$16.86M
10-K · filed 2026-06-26
2024-12-31$3.00M
10-Q · filed 2026-02-13
$7.59M
derived: sum of 2 quarters · filed 2026-02-13
$13.60M
10-Q · filed 2026-02-13
$19.30M
derived: sum of 4 quarters · filed 2026-02-13
2024-09-30$4.58M
10-Q · filed 2025-11-10
$10.59M
10-Q · filed 2025-11-10
$16.29M
derived: sum of 3 quarters · filed 2025-11-10
$23.13M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$6.01M
10-Q · filed 2025-08-12
$11.71M
derived: sum of 2 quarters · filed 2025-08-12
$18.55M
derived: sum of 3 quarters · filed 2025-08-12
$25.68M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$5.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20
$12.54M
derived: sum of 2 quarters · filed 2025-06-20
$19.67M
derived: sum of 3 quarters · filed 2025-06-20
$24.36M
10-K · filed 2025-06-20
2023-12-31$6.84M
10-Q · filed 2025-02-10
$13.97M
derived: sum of 2 quarters · filed 2025-02-10
$18.66M
10-Q · filed 2025-02-10
$22.79M
derived: sum of 4 quarters · filed 2025-02-10
2023-09-30$7.13M
10-Q · filed 2024-11-12
$11.83M
10-Q · filed 2024-11-12
$15.96M
derived: sum of 3 quarters · filed 2024-11-12
$20.96M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$4.70M
10-Q · filed 2024-08-06
$8.83M
derived: sum of 2 quarters · filed 2024-08-06
$13.83M
derived: sum of 3 quarters · filed 2024-08-06
$18.28M
derived: sum of 4 quarters · filed 2024-08-06
2023-03-31$4.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24
$9.13M
derived: sum of 2 quarters · filed 2024-06-24
$13.58M
derived: sum of 3 quarters · filed 2024-06-24
$16.81M
10-K · filed 2024-06-24
2022-12-31$5.00M
10-Q · filed 2024-02-12
$9.45M
derived: sum of 2 quarters · filed 2024-02-12
$12.68M
10-Q · filed 2024-02-12
$16.39M
derived: sum of 4 quarters · filed 2024-02-12
2022-09-30$4.45M
10-Q · filed 2023-11-13
$7.68M
10-Q · filed 2023-11-13
$11.39M
derived: sum of 3 quarters · filed 2023-11-13
$13.93M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$3.23M
10-Q · filed 2023-08-10
$6.94M
derived: sum of 2 quarters · filed 2023-08-10
$9.48M
derived: sum of 3 quarters · filed 2023-08-10
$12.29M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$3.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22
$6.25M
derived: sum of 2 quarters · filed 2023-06-22
$9.06M
derived: sum of 3 quarters · filed 2023-06-22
$11.80M
10-K · filed 2023-06-22
2021-12-31$2.54M
10-Q · filed 2023-02-10
$5.35M
derived: sum of 2 quarters · filed 2023-02-10
$8.09M
10-Q · filed 2023-02-10
$9.94M
derived: sum of 4 quarters · filed 2023-02-10
2021-09-30$2.81M
10-Q · filed 2022-11-08
$5.55M
10-Q · filed 2022-11-08
$7.39M
derived: sum of 3 quarters · filed 2022-11-08
$10.69M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$2.74M
10-Q · filed 2022-08-11
$2.74M
10-Q · filed 2021-08-10
$4.59M
derived: sum of 2 quarters · filed 2022-08-11
$7.88M
derived: sum of 3 quarters · filed 2022-08-11
$11.03M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$1.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-29
$5.14M
derived: sum of 2 quarters · filed 2022-06-29
$8.29M
derived: sum of 3 quarters · filed 2022-06-29
$12.62M
10-K · filed 2022-06-29
$12.62M
10-K · filed 2021-06-10
2020-12-31$3.29M
10-Q · filed 2022-02-10
$3.29M
10-Q · filed 2021-02-09
$6.44M
derived: sum of 2 quarters · filed 2022-02-10
$10.77M
10-Q · filed 2022-02-10
$10.77M
10-Q · filed 2021-02-09
$13.67M
derived: sum of 4 quarters · filed 2022-02-10
2020-09-30$3.15M
10-Q · filed 2021-11-12
$3.15M
10-Q · filed 2020-11-12
$7.48M
10-Q · filed 2021-11-12
$7.48M
10-Q · filed 2020-11-12
$10.37M
derived: sum of 3 quarters · filed 2021-11-12
$12.95M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$4.33M
10-Q · filed 2021-08-10
$7.23M
derived: sum of 2 quarters · filed 2021-08-10
$9.81M
derived: sum of 3 quarters · filed 2021-08-10
$12.66M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$2.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10
$5.48M
derived: sum of 2 quarters · filed 2021-06-10
$8.33M
derived: sum of 3 quarters · filed 2021-06-10
$10.65M
10-K · filed 2021-06-10
2019-12-31$2.58M
10-Q · filed 2021-02-09
$5.43M
derived: sum of 2 quarters · filed 2021-02-09
$7.75M
10-Q · filed 2021-02-09
$9.38M
derived: sum of 4 quarters · filed 2021-02-09
2019-09-30$2.85M
10-Q · filed 2020-11-12
$5.17M
10-Q · filed 2020-11-12
$6.80M
derived: sum of 3 quarters · filed 2020-11-12
$7.39M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$2.32M
10-Q · filed 2020-08-06
$3.95M
derived: sum of 2 quarters · filed 2020-08-06
$4.54M
derived: sum of 3 quarters · filed 2020-08-06
$5.19M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$1.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-23
$2.22M
derived: sum of 2 quarters · filed 2020-06-23
$2.87M
derived: sum of 3 quarters · filed 2020-06-23
$3.93M
10-K · filed 2020-06-23
2018-12-31$588.26K
10-Q · filed 2020-02-07
$586.70K
10-Q · filed 2019-02-14
$1.24M
derived: sum of 2 quarters · filed 2020-02-07
$2.30M
10-Q · filed 2020-02-07
$3.94M
derived: sum of 4 quarters · filed 2020-02-07
2018-09-30$647.87K
10-Q · filed 2019-11-06
$648.00K
10-Q · filed 2018-11-14
$1.71M
10-Q · filed 2019-11-06
$1.71M
10-Q · filed 2018-11-14
$3.35M
derived: sum of 3 quarters · filed 2019-11-06
$4.56M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30$1.06M
10-Q · filed 2019-08-14
$1.06M
10-Q · filed 2018-08-14
$2.70M
derived: sum of 2 quarters · filed 2019-08-14
$3.91M
derived: sum of 3 quarters · filed 2019-08-14
$5.11M
derived: sum of 4 quarters · filed 2019-08-14
2018-05-10$55.90K
10-K · filed 2019-06-28
2018-03-31$1.64M
10-K · filed 2019-06-28
-$1.64M
10-KT · filed 2018-06-15
$2.85M
derived: sum of 2 quarters · filed 2019-06-28
$4.04M
derived: sum of 3 quarters · filed 2019-06-28
$4.64M
10-K · filed 2019-06-28
2017-12-31$1.21M
10-Q · filed 2019-02-14
$2.40M
derived: sum of 2 quarters · filed 2019-02-14
$2.93M
10-Q · filed 2019-02-14
$4.44M
10-K · filed 2019-06-28
$4.44M
10-K · filed 2018-03-30
2017-09-30$1.19M
10-Q · filed 2018-11-14
$1.78M
10-Q · filed 2018-11-14
$3.22M
10-Q · filed 2017-11-03
$1.98M
derived: sum of 4 quarters · filed 2019-06-28
2017-06-30$591.00K
10-Q · filed 2018-08-14
$2.03M
10-Q · filed 2017-08-11
$783.70K
derived: sum of 3 quarters · filed 2019-06-28
$861.70K
derived: sum of 4 quarters · filed 2019-06-28
2017-03-31$1.44M
10-K · filed 2019-06-28
$1.44M
10-Q · filed 2017-05-15
$192.70K
derived: sum of 2 quarters · filed 2019-06-28
$270.70K
derived: sum of 3 quarters · filed 2019-06-28
$541.70K
derived: sum of 4 quarters · filed 2019-06-28
2016-12-31-$1.25M
derived: 10-KT 12 month − 10-Q 9 month · filed 2018-06-15
-$1.17M
derived: sum of 2 quarters · filed 2018-06-15
-$897.00K
derived: sum of 3 quarters · filed 2018-06-15
-$673.00K
10-KT · filed 2018-06-15
$673.00K
10-K · filed 2018-03-30
2016-09-30$78.00K
10-Q · filed 2017-11-03
$349.00K
derived: sum of 2 quarters · filed 2017-11-03
$573.00K
10-Q · filed 2017-11-03
2016-06-30$271.00K
10-Q · filed 2017-08-11
$495.00K
10-Q · filed 2017-08-11
2016-03-31$224.00K
10-Q · filed 2017-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B